Safety and preliminary activity of pembrolizumab‑carboplatin‑paclitaxel in heavily pretreated and/or fragile patients with PDL1‑positive recurrent/metastatic head and neck cancer-Reference-Cited by-同舟云学术

Safety and preliminary activity of pembrolizumab‑carboplatin‑paclitaxel in heavily pretreated and/or fragile patients with PDL1‑positive recurrent/metastatic head and neck cancer

Published:2022-12-07 Issue:1 Volume:25 Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Cabezas‑camarero Santiago¹,Merino‑Menéndez Salomé²,Cabrera‑Martín María³,Sotelo Miguel⁴,Plaza‑Hernández José⁵,Falahat Farzin⁶,Iglesias‑Moreno María⁶,Pérez‑Segura Pedro¹

Affiliation:

1. Head and Neck Cancer, Neuro‑Oncology and Genetic Counseling Unit, Medical Oncology Department, Instituto de Investigación Sanitaria San Carlos, Spain

2. Radiology Department, Clinico San Carlos University Hospital, Madrid 28040, Spain

3. Nuclear Medicine Department, Clinico San Carlos University Hospital, Madrid 28040, Spain

4. Medical Oncology Department, Aliada Cancer Center, San Isidro 15036, Spain

5. Pathology Department, Clinico San Carlos University Hospital, Madrid 28040, Spain

6. Department of Craniomaxilofacial Surgery, Clinico San Carlos University Hospital, Madrid 28040, Spain

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Reference33 articles.

1. Nivolumab for recurrent squamous-cell carcinoma of the head and neck;Ferris;N Engl J Med,2016

2. Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KENOTE-048): A randomised, open-label, phase 3 study;Burtness;Lancet,2019

3. The secret ally: Immunostimulation by anticancer drugs;Galluzzi;Nat Rev Drug Discov,2012

4. Anti-tumor immunity in head and neck cancer: Understanding the evidence, how tumors escape and immunotherapeutic approaches;Allen;Cancers (Basel),2015

5. Cisplatin eligibility issues and alternative regimens in locoregionally advanced head and neck cancer: Recommendations for clinical practice;Szturz;Front Oncol,2019

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neoadjuvant pembrolizumab-carboplatin-paclitaxel in locally advanced squamous cell carcinoma of the oral cavity: A case report and literature review;Oral Oncology Reports;2024-09